Research Article
Botulinum Toxin Suppression of CNS Network Activity In Vitro
Table 1
Antisera protection experiments.
|
Experiment | Tissue type |
Age
(d.i.v.) | SERUM | Delay |
BoNT-A
(ng/mL) |
Protection Yes/No | Experiment duration
(h) | # | Conc. |
| BT-016 | SC | 86 | 76 | 0.3% | 0.3 h | 100 | No | 18 | BT-017 | FC | 28 | 32 | 1.0% | 1.1 h | 100 | No | 8 | BT-019 | FC | 52 | 83 | 5% | 0.4 h | 100 | Yes | 19 | BT-068 | FC | 33 | 4 | 5% | 20 h | 50 | Yes | 50 | BT-070 | FC | 40 | 4 | 1.3% | 3.0 h | 50 | Yes | 15 | BT-072 | SC | 29 | 4 | 0.5% | 1.2 h | 50 | No | 21 | BT-074 | SC | 36 | 4 | 1% | 4.2 h | 50 | No | 18.3 | BT-075 | SC | 37 | 23 | 1% | 2.3 h | 50 | No | 16.8 | BT-076 | FC | 39 | 23 | 2% | 0.7 h | 50 | Yes | 20 | BT-077a | FC | 40 | 23 | 2% | 0.3 h | 50 | Yes | 15.2 | BT-077b | Continuation | | | | 100 | Yes | | BT-077c | Continuation | | | | 150 | Yes | | BT-077d | Continuation | | | | 200 | Yes | 45 |
|
|
FC: frontal cortex; SC: spinal cord. Delay: time between serum addition and BoNT-A addition.
|